Cited by 197Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesPancreatic function and diabetes

Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat.

Chinookoswong, N, Wang, J L, Shi, Z Q·1999·Diabetes

Abstract

Leptin has been shown to improve insulin sensitivity and glucose metabolism in normoinsulinemic healthy or obese rodents. It has not been determined whether leptin may act independently of insulin in regulating energy metabolism in vivo. The present study was designed to examine the effects of leptin treatment alone on glucose metabolism in insulin-deficient streptozotocin (STZ)-induced diabetic rats. Four groups of STZ-induced diabetic rats were studied: 1) rats treated with recombinant methionine murine leptin subcutaneous infusion with osmotic pumps for 12-14 days (LEP; 4 mg x kg(-1) x day(-1), n = 10); 2) control rats infused with vehicle (phosphate-buffered saline) for 12-14 days (VEH; n = 10); 3) pair-fed control rats given a daily food ration matching that of LEP rats for 12-14 days (PF; n = 8); and 4) rats treated with subcutaneous phloridzin for 4 days (PLZ; 0.4 g/kg twice daily, n = 10). Phloridzin treatment normalizes blood glucose without insulin and was used as a control for the effect of leptin in correcting hyperglycemia. All animals were then studied with a hyperinsulinemic-euglycemic clamp (6 mU x kg(-1) x min(-1). Our study demonstrates that leptin treatment in the insulin-deficient diabetic rats restored euglycemia, minimized body weight loss due to food restriction, substantially improved glucose metabolic rates during the postabsorptive state, and restored insulin sensitivities at the levels of the liver and the peripheral tissues during the glucose clamp. The effects on glucose turnover are largely independent of food restriction and changes in blood glucose concentration, as evidenced by the minimal improvement of insulin action and glucose turnover parameters in the PF and PLZ groups. Our results suggest that the antidiabetic effects of leptin are achieved through both an insulin-independent and an insulin-sensitizing mechanism.

Integrity signals

Registry

Crossref · 10.2337/diabetes.48.7.1487

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hyperleptinemia induced by pharmacological leptin administration or adenoviral gene therapy fully ameliorates hyperglycemia in STZ-induced diabetic rats even with extremely low plasma insulin levels.

    “hyperleptinemia induced by either pharmacological leptin administration (34) or with adenoviral gene therapy (210) fully ameliorates hyperglycemia in STZ-induced diabetic rats, even in the face of extremely low plasma insulin levels.”
  • Pharmacological administration of leptin systemically can normalize blood glucose levels in rodent models of uncontrolled diabetes mellitus.

    “recent evidence suggests that pharmacological administration of leptin systemically (3,4) can also normalize blood glucose levels in rodent models of uncontrolled diabetes mellitus (uDM).”

Cited by

Sorted by citations

Authors
Chinookoswong, N., Wang, J. L., & Shi, Z. Q.
Affiliations
Amgen (United States) (US)
Venue
Diabetes
Published
1999-07-01
Volume
48
Issue
7
Pages
1487-1492
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2113808580
Cited by
197
References
0
Citations by year
2022: 4 · 2021: 6 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 11 · 2016: 14 · 2015: 9 · 2014: 11 · 2013: 12 · 2012: 13
FWCI
4.16
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
leptin, insulin-deficient diabetes, streptozotocin-induced diabetes, glucose turnover, normoglycemia, insulin sensitivity, hyperinsulinemic-euglycemic clamp, phloridzin, dietary restriction, weight loss, peripheral insulin action
MeSH terms
Animals, Diabetes Mellitus, Experimental, Drug Evaluation, Preclinical, Glucose, Insulin, Male, Obesity, Phlorhizin, Proteins, Glucose Clamp Technique, Rats, Sprague-Dawley, Leptin, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review